Cellevate
Long Beach, US · Founded 2025 · Delaware corporation · 21 employees on LinkedIn · 5 known investors
Find your way into Cellevate
74 people in our graph share verified history with the Cellevate team — schools, employers, funds. One of them is your warm intro.
Alexander Fred-Ojalaunlockedknows Maximilian Ottosson · together at The Faculty of Engineering at Lund University (overlapped)
×10knows the team · via The Faculty of Engineering at Lund University
knows the team · via Cellevate AB
Cellevate develops Cellevat3d nanofiber-based microcarriers and cell culture systems for upstream bioprocessing, used in viral vector, viral vaccine, and stem cell production by gene therapy and biopharmaceutical organizations. Founded as a spinout from NanoLund and Prof. Lars Montelius's group, the company focuses on commercializing nanofiber cell culture technology.
Founders & leadership
Cellevate was founded in 2025 by Maximilian Ottosson.
MO
Maximilian OttossoninFounderMaximilian Ottosson co-founded Cellevate, a nanofiber-based cell culture company spun out from NanoLund, where he held roles including CEO and COO and oversaw company building, fundraising, and commercial operations. He brings over a decade of experience in deeptech and biotech commercialization.
CM
Clint MonfortNamed on SEC filing
Investors · 5
Funding
SEC filings, press & company announcements$25K disclosed across 1 of 6 rounds · 2023–2026
- Undisclosed amountSeed FinancingJun 2026Source ↗
- Undisclosed amountSeed FinancingOct 2023 · 3 sources
Industrifonden (lead), European Innovation Council Fund (EIC Fund), Onsight Ventures
Source ↗
▶$25KraisedJun 2025 · 1 investors · OtherRule 506(b)
▶$25KraisedJun 2025 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Clint MonfortExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $25K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 04, 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Agilent4 shared keywordsAgilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors. The company operates through three segments: Life Sciences and Diagnostics Markets (which includes contract manufacturing services for oligonucleotide therapeutics and pathology solutions), Agilent CrossLab (providing lab services and automation), and Applied Markets (offering analytical instruments and software).
Cellares3 shared keywordsCellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies. The company serves biopharmaceutical manufacturers and cell therapy developers worldwide.
Celldex Therapeutics, Inc.3 shared keywordsCelldex is a biotechnology company developing therapeutics across therapeutic areas including immunology and inflammation. The page shown is a board director biography rather than a company overview.
Cellphire3 shared keywordsCellphire Therapeutics develops platelet-based and freeze-dried cellular therapeutics for transfusion medicine, focused on controlling hemorrhage. Through its veterinary subsidiary BodeVet, it also markets freeze-dried platelet products for companion and exotic animals.
Companies competing with Cellevate for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Cellevate do?
- Cellevate develops Cellevat3d nanofiber-based microcarriers and cell culture systems for upstream bioprocessing, used in viral vector, viral vaccine, and stem cell production by gene therapy and biopharmaceutical organizations. Founded as a spinout from NanoLund and Prof. Lars Montelius's group, the company focuses on commercializing nanofiber cell culture technology.
- Who founded Cellevate?
- Cellevate was founded by Maximilian Ottosson in 2025.
- Who are Cellevate's investors?
- Cellevate's investors include Industrifonden, European Investment Bank, Onsight Ventures, EIC, European Innovation Council Fund.
- How much funding has Cellevate raised?
- Cellevate has disclosed $25K raised across 1 of its 6 known rounds.
- Where is Cellevate headquartered?
- Cellevate is headquartered in Long Beach, US.